Metagenomic analysis reveals crosstalk between gut microbiota and glucose-lowering drugs targeting the gastrointestinal tract in Chinese patients with type 2 diabetes: a 6 month, two-arm randomised trial.
Diabetologia
; 65(10): 1613-1626, 2022 10.
Article
in En
| MEDLINE
| ID: mdl-35930018
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Diabetes Mellitus, Type 2
/
Gastrointestinal Microbiome
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Humans
Country/Region as subject:
Asia
Language:
En
Journal:
Diabetologia
Year:
2022
Type:
Article
Affiliation country:
China